BALCHEM CORP
10KSB/A, 1998-10-27
CHEMICALS & ALLIED PRODUCTS
Previous: AMP INC, DFAN14A, 1998-10-27
Next: BRIDGES INVESTMENT FUND INC, N-30B-2, 1998-10-27



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                      ------------------------------------

                                  FORM 10-KSB/A

                                 (Amendment #1)

                      ------------------------------------

                 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d)

                     OF THE SECURITIES EXCHANGE ACT OF 1934

                   For the fiscal year ended December 31, 1997

                         Commission file number 1-13648

                               BALCHEM CORPORATION
             (Exact name of Registrant as specified in its charter)

         Maryland                                           13-2578432
- -------------------------------                       ---------------------- 
(State or other jurisdiction of                         (I.R.S. Employer 
incorporation or organization)                        Identification Number)

  PO Box 175, Slate Hill, New York                   10973
(Address of principle executive office)                      (Zip Code)

Registrant's telephone number, including area code:  (914) 355-5300
                                                     --------------

Securities registered persuant to Section 12 (b) of the Act:

                                                       Name of each exchange
 Title of each class                                   on which registered
 -------------------                                   -------------------

 Common Stock, par value $.06-2/3 per share           American Stock Exchange

          Securities registered pursuant to Section 12(g) of the Act;

                                      None
                                ----------------
                                (Title of Class)

                  Check if disclosure  of delinquent  filers in response to Item
405 of Regulation S-B is not contained in this form,  and no disclosure  will be
contained  to  the  best  of  Registrant's  knowledge  in  definitive  proxy  or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [ X ]

                  State  Registrant's  revenues for its most recent fiscal year.
$28,619,000.
<PAGE>
                  State the  aggregate  market value of the voting stock held by
non-affiliates  of  Registrant  computed by  reference to the price at which the
stock was sold,  or the  average  bid and asked  prices of such  stock,  as of a
specified date within the past 60 days.

                  $42,246,245 is the aggregate  market value of the voting stock
held by non-affiliates of Registrant as of March 1, 1998.

                  State the number of shares outstanding of each of Registrant's
classes of common equity as of the latest practicable date.

                   3,197,362  shares of common  stock,  par value  $.06-2/3  per
share ("Common stock"), were outstanding as of March 1, 1998.

                  The proxy statement for the Annual Meeting to be held June 19,
1998, is incorporated by reference in Part III.

                  Check whether Registrant (1) has filed all reports required to
be filed by Section 13 or 15 (d) of the  Securities  Exchange Act of 1934 during
the past 12 months (or for such shorter  period that  Registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days.

                  Yes   [ X ]    No      [   ]
<PAGE>
Item 8.  Changes in and Disagreements with Accountants on Accounting and 
         Financial Disclosure
   
         On  December  30,  1996,  Registrant  advised  the  accounting  firm of
Judelson, Giordano, Siegel, CPA, PC, the principal accountant previously engaged
to audit Registrant's financial statements that it was dismissing such principal
accountant for audits of years after December 31, 1996.

         During the Registrant's two most recent fiscal years the reports issued
by the former  accountants  on the  Registrant's  financial  statements  did not
contain an adverse opinion or a disclaimer of opinion,  nor was any such opinion
qualified or modified as to uncertainty, audit scope, or accounting principles.

         The  decision  to  change  accountants  was  recommended  by the  Audit
Committee  and approved by the Board of Directors.  There were no  disagreements
with the former accountant on any matter of accounting  principles or practices,
financial statement disclosures or auditing scope or procedures.

         The Company has engaged  KPMG Peat  Marwick LLP as its new  independent
accountants for periods after December 31, 1996. The selection was the result of
a competitive search process initiated by the Company.

         The above noted information was disclosed in Registrants Form 8-K dated
January 9, 1997.
    
Item 13. Exhibits and Reports on Form 8-K

         (a)      Exhibits:

         (3)(i)  Articles of  Amendment  to Articles of  Restatement  (replacing
Articles of Incorporation of registrant,  as previously filed),  incorporated by
reference from the December 31, 1988 Form 10-K filed with the Commission.

         (3)(ii)  By-laws  of  registrant,  as  amended  on  December  6,  1985,
incorporated  by reference from the Form 10-K filed with the Commission on March
27, 1986.
   
         (16)     Letter on change in certifying accountant.
    
         (23)(i)  Consent of KPMG Peat Marwick LLP, Independent Auditors 
         (23)(ii) Consent of Judelson, Giordano, Siegel, P.C.

         (b) No reports on Form 8-K were  filed  during the last  quarter of the
year ended December 31, 1997.
<PAGE>


In  accordance  with Section 13 or 15(d) of the  Exchange  Act,  Registrant  has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

         BALCHEM CORPORATION

         By:/s/ Dino A. Rossi
         --------------------
         Dino A. Rossi, President,
         Chief Executive Officer

         Date: October 23, 1998


<PAGE>


                  In  accordance  with the  Exchange  Act,  this report has been
signed by the following  persons on behalf of Registrant  and in the  capacities
and on the dates indicated.

                                         By:/s/ Dino A. Rossi
                                            -----------------
                                            Dino A. Rossi, President,
                                            Chief Executive Officer and
                                            Director
                                            Date: October 23, 1998

                                         By:/s/ Donald E. Alguire
                                            ---------------------
                                            Donald E. Alguire, Director
                                            Date: October 23, 1998

                                         By:/s/ John E. Beebe
                                            -----------------
                                            John E. Beebe, Director
                                            Date: October 23, 1998

                                         By:/s/ Francis X. McDermott
                                            ------------------------
                                            Francis X. McDermott, Director
                                            Date: October 23, 1998

                                         By:/s/ Kenneth P. Mitchell
                                            -----------------------
                                            Kenneth P. Mitchell, Director
                                            Date: October 23, 1998

                                         By:/s/ Carl R. Pacifico
                                            --------------------
                                            Carl R. Pacifico, Director
                                            Date: October 23, 1998

                                         By:/s/ Israel Sheinberg
                                            --------------------
                                            Israel Sheinberg, Director
                                            Date: October 23, 1998

                                         By:/s/ Leonard J. Zweifler
                                            -----------------------
                                            Leonard J. Zweifler, Director
                                            Date: October 23, 1998


   
                                                                      Exhibit 16

                                                                October 19, 1998

Securities and Exchange Commission
Washington, D.C. 20549

Gentlemen:

         We have received from Balchem Corporation its form 8-K dated January 9,
1997 in which Balchem  Corporation  provides reasons for its change in principal
accountants. We do not disagree with the reasons provided in that document.

                                         Very Truly Yours,

                                         /s/ Judelson, Giordano, Siegel, CPA, PC
                                         ---------------------------------------
                                             Judelson, Giordano, Siegel, CPA, PC
    



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission